Optiscan has been featured in Stockhead's Long Shortz where Optiscan CEO Dr. Camile Farah spoke with Tylah Tully to discuss the launch of the company’s breast cancer study with the Mayo Clinic.

Dr Farah also explains how its InVue and InForm technologies could improve surgical outcomes and the remaining milestones on the path to FDA submissions later this year.

Watch the full interview here.